Alzheimer’s and Parkinson’s Disease Chan, Joanna & Dorisca, Lamar.

Slides:



Advertisements
Similar presentations
MOTOR NEURON DISEASE The motor neuron diseases (or motor neuron diseases) (MND) are a group of neurological disorders that selectively affect motor neurons.
Advertisements

Curtin University is a trademark of Curtin University of Technology CRICOS Provider Code 00301J Curtin University is a trademark of Curtin University of.
Martha Stearn, MD Institute for Cognitive Health St John’s Medical Center Jackson, Wyoming.
Neurological Diseases/Injuries/Disorders What can you do to protect your nervous system?
What can you do to protect your nervous system?. Epilepsy Most common neurological disorder in US Seizure disorder(must have 2 or more)—electrical impulses.
Primary Symptoms It is important to note that not all patients experience the full range of symptoms; in fact, most do not. Rigidity is an increased tone.
Dementia Drugs: Mainstream and Alternative Medicines Susan Kurrle.
What is Aging? Alzheimer’s Disease Parkinson’s Disease.
The Brain. Problems with the Brain… Dementia – group of symptoms affecting intellectual and social abilities severely enough to interfere with daily.
Cognitive Enhancers. Dementia A syndrome due to disease of the brain, characterised by progressive, global deterioration in intellect including: Memory.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 22 Alzheimer’s Disease.
Decision presented by the committee board members: Nicholas Mann & Katelyn Strasser FUTURE FUNDING FOR ALZHEIMER’S DISEASE October 14, 2014 MPH 543 Leadership.
Alzheimer’s Disease Angela Singh, PharmD Associate Professor of Pharmacy Practice Florida A&M University College of Pharmacy & Pharmaceutical Sciences.
Neurodegeneration is the umbrella term for the progressive loss of structure or function of neurons, including death of neurons. Many neurodegenerative.
Chapter 30 Agents Used to Treat Parkinson’s Disease.
ALZHEIMER’S PART 2. AD VIDEO
ALZHEIMER’S DISEASE BY JOSEPH MOLLUSO.
Pharmacological Management. Only symptomatic treatment, there is no cure. Acetylcholinesterase inhibitors - Only for mild to moderate dementia –Donepezil.
Copyright © 2007, 2003 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 37 Confusion and Dementia.
LISA JOHNSON & SUZANNE GRIESEL MPH 543 LEADERSHIP AND ORGANIZATIONAL BEHAVIOR FEBRUARY 16, 2014 Funding Analysis of Alzheimer’s Treatment Options: Three.
By: Tasso Skountzouris David Schiano. General Description  Alzheimer’s is one the most common form of Dementia  Dementia causes a loss of brain function.
Alzheimer disease and other mental impairments Medications for Alzheimer disease Zvereva Mila school of pharmacy.
PARKINSON’S DISEASE By Courtney and Niral. WHAT IS IT?  Parkinson's disease (PD) is chronic and progressive movement disorder, meaning that symptoms.
Adult Medical-Surgical Nursing Neurology Module: Parkinson’s Disease.
Medical University of Sofia, Faculty of Medicine Department of Pharmacology and Toxicology Alzheimer’s Disease Avi Gandhi (2009)
COLUMBIA PRESBYTARIAN HOSPITAL CENTER
Parkinson’s Disease by Jessica Teen Health 8 Definition *Parkinson’s Disease is a disorder of the brain characterized by shaking and having difficulty.
Rivastigmine Tartrate Presented by: Mona Abdulrahman Alkallabi Mona Abdulrahman Alkallabi.
Parkinson’s Disease Dr. Andrew Schmelz, PharmD Post-Doctoral Teaching Fellow Dept of Pharmacy Practice Purdue University March 4, 2009.
Alzheimer's: An Investigation into Treatment Options Dana McGuire and Jessica Scharfenberg MPH 543: Leadership and Organizational Management Concordia.
CAROLINE HARADA, M.D. ASSOCIATE PROFESSOR OF MEDICINE UAB DIVISION OF GERONTOLOGY, GERIATRICS, AND PALLIATIVE CARE NOVEMBER 2013 Dementia.
DISORDERS OF THE NERVOUS SYSTEM (NS). Multiple Sclerosis  Affects nerve cells of brain and spinal cord  It is believed to be an autoimmune disorder,
Alzheimer's Disease BIOLOGY 1409 Presentation By XXXXXXXXXX May 3, 2010.
Number of neurotransmitters  Neurotransmitters are chemicals capable of transmitting a signal from the pre-synaptic to the post synaptic neurone  Over.
James Smith Pd.803/15/10. What is Alzheimer’s Disease This is a progressive degenerating disease which means that it worsens over time. The estimated.
SYMPTOMS: Tremors, stiff muscles Shuffling gait, Poor coordination Balance problems, Fatigue Speech & swallowing difficulties TREATMENTS: Medications.
Mosby items and derived items © 2008 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 44 Confusion and Dementia.
Dementia: Alzheimer’s Disease Cyril Evbuomwan Patient Group Meeting 1 st December 2015.
Amyotrophic lateral sclerosis
Dementia Care Wendy Burnett CNS for Older People.
BY: AMAN SINGH AND ALLY MATTINGLY Alzheimer's Disease.
The Substantia Nigra THE BRAIN Symptoms differ from every person suffering from the disease. There are two types of symptoms, primary, secondary.
Kynnera Stephenson Lubbock Christain University \.
Chapter 29 Central Nervous System Stimulants Used to Treat Attention Deficit Hyperactivity Disorder and Agents Used to Treat Alzheimer’s Disease.
Alzheimer’s Disease By:Jeorzsees Ang, Becky Carrasco, Eunice Choi, and Deborah De La Puente.
Drugs Used for Parkinson’s Disease Chapter 15 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Neurotransmitters in the brain By Joon Kim. Neurotransmitters  A neurotransmitter is a specialized messenger chemical that transfers or sends information.
Diseases and Disorders of the Nervous System. schizophrenia Characterized by psychotic episodes involving hallucinations & delusions Genetic & environmental.
Primary Symptoms It is important to note that not all patients experience the full range of symptoms; in fact, most do not. Rigidity is an increased tone.
Do Now 2/9/15 1.Describe possible causes for forgetting a memory. 2.Compare and contrast semantic and episodic memories.
ALZHEIMER’S DISEASE AHII.
“HEALTH IS THE BEST” In the name of God. WHAT IS IT? Parkinson's disease (PD) is a chronic and progressive movement disorder, meaning that symptoms.
PARKINSON’S DISEASE LUKE CARROLL & LAUREN DESROCHES.
Parkinson’s disease by Syed Baseeruddin Alvi (09).
Drugs Used for Parkinson’s Disease
Neurodegenerative Disorders
Lexapro By: Gina Caprara.
Neurocognitive Disorders
Alzheimer’s Disease.
Parkinson’s Disease Celsey and Chylee.
Treatment of Parkinson’s disease
Medications for Dementia
ANTIPARKINSONS Drugs By Dr. Mirza Shahed Baig.
Erin Blackshear Amber Burks Danielle Chelette
Alzheimer’s Disease Medical University of Sofia, Faculty of Medicine
Figure 19.1 Alzheimer disease and the resulting dementia occur when changes in the brain hamper neurotransmission.
INTRODUCING 3 DISEASES THAT AFFECTS THE NERVE SYSTEM
Drugs for Degenerative Diseases of the Nervous System
Cholinesterase Inhibitors: Actions and Uses
ALZHEIMER’s Disease By: Marianne Gomez.
Presentation transcript:

Alzheimer’s and Parkinson’s Disease Chan, Joanna & Dorisca, Lamar

What is Alzheimer’s Disease Alzheimer’s disease is a form of dementia. It is a progressive neurological disease that affects the memory, thinking, and language areas of the brain. Alzheimer’s causes changes in the brain nerve cells and these changes cannot be reversed. Alzheimer’s disease generally occurs in the elderly population. After the age of 65 the incidence of this disease doubles every five years.

Stages of Alzheimer’s (Symptoms) ① During the first stage a person with Alzheimer’s will start to be forgetful. They will start to have trouble with finding what words the want to say. ② At this stage the person’s memory will worsen. Along with becoming more forgetful, their speech also becomes worse. They have problems with self care and may even start to have hallucinations. ③ In this stage the person will be bedridden, mute and experience encopresis.

Treatment Despite the extensive research done on this disease there is no cure for it. Certain medications are used to help with the management of this disease. There two types of drugs used for the management of mild to moderate cases and moderate to severe cases. Cholinesterase inhibitors are used for mild to moderate cases. N-methyl D-aspartate antagonist are used for moderate to severe cases.

Cholinesterase Inhibitors MOA: Inhibit the breakdown of cholinesterase, which is an essential chemical in the brain for memory and thinking. It cannot be used for severe Alzheimer’s because as the disease progresses the brain produces less cholinesterase. There are three types of drugs in this category that is used for Alzheimer’s.

Cholinesterase Inhibitors (cont.’d) Razadyne (galantamine) - Common side effects include: Nausea, vomiting, diarrhea, weight loss, loss of appetite. Exelon (rivastigmine) - Common side effects include: Nausea, vomiting, diarrhea, weight loss, loss of apvpetite, muscle weakness. Aricept (donepezil) – Common side effects include: Nausea, vomiting, diarrhea. Drug Interactions: May increase effects of antipsychotics; beta-blockes; cholinergic agonist. Anticholinergics; neuromuscular-blocking agents & St. John’s Wort may decrease the effect of donepezil.

N-methyl D-aspartate antagonist Mechanism Of Action To control glutamate, which is an important brain chemical, and its activation. Excess glutamate can have toxic effects. Drug Used Namenda (memantine) – Common side effects include: Dizziness, headache, constipation, confusion.

Dental Team Patients with Alzheimer’s may be neglectful of their dental health and oral hygiene, because of their forgetfulness. Medications they are taking can cause Xerostomia, which can lead to an increase in caries. The patient should brush twice a day with a powered toothbrush to make it easier on the patient and/or caregiver. If toothpaste poses a problem than it should not be used. Floss teeth once a day. Since patients with Alzheimer’s do not swallow well, their denture (if one is worn) should be removed and cleaned after every meal and the gingival and palate should be brushed with a soft toothbrush. The patient should have a monthly check-up dental appointment.

Parkinson’s Parkinson’s disease is a disabling condition of the brain characterized by slowness of movement, shaking, stiffness, and in later stages, loss of balance. This is due to the lack of dopamine being produced in the brain. Dopamine is a neurotransmitter; it is a chemical messenger that helps in transmission of signals in the brain and other vital areas. Dopamine regulates emotional responses, our “fight or flight” response, cognitive functions (concentration, memory and problem solving), and more importantly movement. Nerve cells that are responsible for making dopamine are slowly deteriorating. Without dopamine, the brain cannot properly send messages, resulting in loss of muscle function.

Symptoms Tremors Difficulties in walking, eating, swallowing and balancing Memory loss Dry mouth Depression and more There is no cure for PD, but we do have medications that can control these symptoms.

Dopamine Precursor Levodopa & Carbidopa are used together. MOA: Levodopa converts into dopamine, Carbidopa prevents the breakdown of Levodopa in the bloodstream, therefore increasing Levodopa in the brain and reducing side effects. It also enhances Levodopa. Adverse Effects: Dizziness, nausea/vomiting, anxiety, confusion, clumsiness, and ETC. Drug Interactions: Vitamin B6, Clorgyline, Iproniazid, Pargyline, Phenelzine, Isocarboxazid, and ETC. Contradictions: Diabetes mellitus, heart or blood vessel disease, kidney illness, seizure disorders, and ETC.

Dental Team Patients with PD will most likely present calculus and/or caries due to poor oral hygiene care. We would recommend a PD patient to use a power brush and an automatic flosser to help cope with the difficulties. Since there is a risk of choking in PD patients, 5% Na fluoride varnish or Stannous fluoride gel can be used. If the patient wears dentures, he/she should remove it once a day and clean it with a denture brush and/or Polident. Make the appointment shorter/more visits, rather than longer/less visit

Alzheimer's & Parkinson’s